Source comparison
CJC-1295 With DAC vs Without DAC
“CJC-1295 with DAC” usually refers to the long-acting drug affinity complex version. “CJC-1295 without DAC” is often used online to describe a shorter-acting modified GRF 1-29-type peptide, but FDA documents warn that CJC-related naming is inconsistent and tha
This comparison does not assign a generated winner or score.
- “CJC-1295 with DAC” usually refers to the long-acting drug affinity complex version. “CJC-1295 without DAC” is often used online to describe a shorter-acting modified GRF 1-29-type peptide, but FDA documents warn that CJC-related naming is inconsistent and that related substances should not be treated as interchangeable [10].
- The practical research distinction is exposure. DAC is intended to extend half-life, while shorter-acting GHRH analogs are often discussed in relation to more transient signaling [2], [3], [10].